CVS Pharmacy announced it’s pulling the heartburn medication Zantac from its shelves over a possible link to cancer. The popular over-the-counter drug and CVS’ own generic brand — ranitidine — will ...

CHICAGO (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of ...

Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Aug 27 (Reuters) - Delaware's highest court said on Tuesday it will hear an appeal by GSK (GSK.L), opens new tab and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued ...

A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes cancer ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar ...

The verdict, in a case brought by plaintiff Angela Valadez, comes two years after a federal judge tossed all the plaintiffs' experts in the Zantac multidistrict litigation. Additional Zantac jury ...

The Food and Drug Administration announced that the popular heartburn medication Zantac, or ranitidine, and some generic versions of the medication, could have an impurity that could cause cancer. The ...

Ranitidine (as HCl) 1mg/mL in sodium chloride 0.45%; IV infusion; preservative-free. History of acute porphyria: not recommended. Renal impairment: reduce dose. Hepatic dysfunction. Discontinue if ...